Advances in Host-Directed Therapies Against Tuberculosis
Latest Publications

TOTAL DOCUMENTS

22
(FIVE YEARS 0)

H-INDEX

0
(FIVE YEARS 0)

Published By Springer International Publishing

9783030569044, 9783030569051
Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Autophagy as a Target for Host-Directed Therapy Against Tuberculosis

2020 ◽  
pp. 71-95
Author(s):  
Surbhi Verma ◽  
Raman Deep Sharma ◽  
Dhiraj Kumar

The Mammalian Target of Rapamycin Complex 1 (mTORC1): An Ally of M. tuberculosis in Host Cells

2020 ◽  
pp. 27-40
Author(s):  
Natalie Bruiners ◽  
Valentina Guerrini ◽  
Maria Laura Gennaro
Keyword(s):  
Mammalian Target Of Rapamycin ◽  
Host Cells ◽  
Target Of Rapamycin

Pharmacological Considerations for Clinical Trials of Host-Directed Therapies for Tuberculosis

2020 ◽  
pp. 311-332
Author(s):  
Elisa H. Ignatius ◽  
Kelly E. Dooley
Keyword(s):  
Clinical Trials

C3HeB/FeJ as a Key Mouse Strain for Testing Host-Directed Therapies Against Tuberculosis

2020 ◽  
pp. 267-273
Author(s):  
Pere-Joan Cardona ◽  
Cristina Vilaplana
Keyword(s):  
Mouse Strain

In Vitro Models of Human Granuloma Formation to Analyze Host-Directed Therapies

2020 ◽  
pp. 259-265
Author(s):  
Liku B. Tezera ◽  
Michaela T. Reichmann ◽  
Basim Al Shammari ◽  
Paul T. Elkington
Keyword(s):  
In Vitro Models ◽  
Granuloma Formation

Alveolar Epithelial Cells

2020 ◽  
pp. 247-255
Author(s):  
Angélica M. Olmo-Fontánez ◽  
Jordi B. Torrelles
Keyword(s):  
Epithelial Cells ◽  
Alveolar Epithelial Cells ◽  
Alveolar Epithelial

Metformin: A Leading HDT Candidate for TB

2020 ◽  
pp. 97-108
Author(s):  
Amit Singhal ◽  
Hardy Kornfeld

Outcomes for Clinical Trials of Host-Directed Therapies for Tuberculosis

2020 ◽  
pp. 295-310
Author(s):  
Akshay N. Gupte ◽  
Sara C. Auld ◽  
William N. Checkley ◽  
Gregory P. Bisson
Keyword(s):  
Clinical Trials
Load More ...
Sign in / Sign up

Export Citation Format

Share Document